Monday, January 30, 2017

BRIEF-Tigenix enrolls first patient in phase Ib/IIa clinical trial of CX611 in severe sepsis

* Enrolls first patient in phase Ib/IIa clinical trial of CX611 in severe sepsis

Source text for Eikon:

Further company coverage:

(Gdynia Newsroom)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)